Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24434091 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Bexarotene (Targretin LGD1069);   Drug: bexarotene

Indicates status has not been verified in more than two years